Emanuele Sasso (E Sasso)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Cancers

International journal of molecular sciences

Cancer gene therapy

mAbs

Department of molecular medicine and medical biotechnology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Department of molecular medicine and medical biotechnology

Italy

PHD

Publications

A Finizio, P Pagano, A Napolano, G Froechlich, L Infante, A De Chiara, S Amiranda, E Vitiello, S Totaro, C Capasso, M Raia, A M D'Alise, P de Candia, N Zambrano, Emanuele Sasso
Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus. Cancer gene therapy (2024)
Lorella Tripodi, Emanuele Sasso, Sara Feola, Ludovica Coluccino, Maria Vitale, Guido Leoni, Barbara Szomolay, Lucio Pastore, Vincenzo Cerullo
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies. Cancers 15 (4) (2023)
Lorella Tripodi, Emanuele Sasso, Sara Feola, Ludovica Coluccino, Maria Vitale, Guido Leoni, Barbara Szomolay, Lucio Pastore, Vincenzo Cerullo
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies. Cancers 15 (4) (2023)
Margherita Passariello, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, Claudia De Lorenzo
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International journal of molecular sciences 24 (12) (2023)
Margherita Passariello, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, Claudia De Lorenzo
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International journal of molecular sciences 24 (12) (2023)
Lorella Tripodi, Emanuele Sasso, Sara Feola, Ludovica Coluccino, Maria Vitale, Guido Leoni, Barbara Szomolay, Lucio Pastore, Vincenzo Cerullo
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies. Cancers 15 (4) (2023)
Margherita Passariello, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, Claudia De Lorenzo
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International journal of molecular sciences 24 (12) (2023)
Rosa Rapuano Lembo, Lorenzo Manna, Guendalina Froechlich, Emanuele Sasso, Margherita Passariello, Claudia De Lorenzo
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC. Cancers 14 (21) (2022)
Margherita Passariello, Veronica Ferrucci, Emanuele Sasso, Lorenzo Manna, Rosa Rapuano Lembo, Stefano Pascarella, Giovanna Fusco, Nicola Zambrano, Massimo Zollo, Claudia De Lorenzo
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab. International journal of molecular sciences 23 (10) (2022)
Nicola Zambrano, Guendalina Froechlich, Dejan Lazarević, Margherita Passariello, Alfredo Nicosia, Claudia De Lorenzo, Marco J Morelli, Emanuele Sasso
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand. Cancers 14 (5) (2022)
Chiara Gentile, Arianna Finizio, Guendalina Froechlich, Anna Morena D'Alise, Gabriella Cotugno, Sara Amiranda, Alfredo Nicosia, Elisa Scarselli, Nicola Zambrano, Emanuele Sasso
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance. International journal of molecular sciences 22 (24) (2021)
Cinzia Vetrei, Margherita Passariello, Guendalina Froechlich, Rosa Rapuano Lembo, Emanuele Sasso, Nicola Zambrano, Claudia De Lorenzo
Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC. Cancers 14 (1) (2021)
Emanuele Sasso, Chiara D'Avino, Margherita Passariello, Anna Morena D'Alise, Daniela Siciliano, Maria Luisa Esposito, Guendalina Froechlich, Riccardo Cortese, Elisa Scarselli, Nicola Zambrano, Alfredo Nicosia, Claudia De Lorenzo
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. mAbs 10 (7) (2018)

Emanuele Sasso.css-eqlu8i{font-size:small;padding-left:4px;} (E Sasso)

Publication Activity (10 Years)

Top Topics

Top Venues

Emanuele Sasso (E Sasso)